NDC 68180-893-71 - PIRMELLA 7/7/7
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-893
- Requested NDC
- 68180-893-71
- Package NDCs from labels
- 68180-893-71, 68180-893-73, 68180-893-11, 68180-893-13
- Manufacturer
- Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
- Effective date
- 2022-12-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PIRMELLA 7/7/7 - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2022-12-20 | HUMAN PRESCRIPTION DRUG LABEL |
| PIRMELLA 7/7/7 - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2019-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PIRMELLA 1/35 - Lupin Pharmaceuticals, Inc. | Lupin Pharmaceuticals, Inc. | 2013-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-893-11 | PIRMELLA 1/35 | 1 in 1 BLISTER PACK | KIT | 1 | 5 | |
| 68180-893-13 | PIRMELLA 1/35 | 3 in 1 CARTON | KIT | 3 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-893-11 | EA - Each | 68180-893 | 7a82d291-17bf-4937-bcf0-724a994fa561 | 1 | 2013-08-02 |
| 68180-893-13 | EA - Each | 68180-893 | 242e3b42-5dc6-493f-a83b-290abda14915 | 1 | 2013-08-02 |
| 68180-893-71 | EA - Each | 68180-893 | 2003e851-3c98-4ec1-961b-b22fb330b675 | 1 | 2019-12-10 |
| 68180-893-73 | EA - Each | 68180-893 | fbcf67d8-ba97-471b-9847-c3641e3b2f6d | 1 | 2019-12-10 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Iclevia | LEVONORGESTREL AND ETHINYL ESTRADIOL | Aurobindo Pharma Limited | 00657f4e-9df8-4f58-91a0-eff5a467f988 | 2024-07-02 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Natazia | ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST | Bayer HealthCare Pharmaceuticals Inc. | 02c91fba-9c47-43ef-ac78-e82369798834 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Azurette | DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | Dr. Reddys Laboratories Inc. | f0288c8d-6ca0-41fa-93f2-b6c2d073891f | 2024-06-25 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Etonogestrel and Ethinyl Estradiol Vaginal Ring | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL RING | Northstar Rx LLC | 1488f5ae-3b34-fcd7-6049-215929b1d324 | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| EnilloRing | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | Xiromed, LLC | 85a126f6-d3e0-9e12-73f9-6176ba36f58b | 2024-06-24 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Apri 28 Day | DESOGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | 3448d121-d00a-4752-8782-416b7a376f3f | 2024-06-12 | Warnings, Adverse reactions | 748797 |
| Zovia 1/35 | ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL TABLETS | Dr. Reddys Laboratories Inc. | fb636d42-cc1d-47f7-974d-c97c79207f3e | 2024-06-01 | Warnings, Adverse reactions | 748797 |
| Tri-Lo- Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 90f7ab24-7839-4408-9a74-07bb6a79eacc | 2024-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Tri-Estarylla | NORGESTIMATE AND ETHINYL ESTRADIOL | Bryant Ranch Prepack | 6560d15f-6ce9-4f0e-9b59-043dec35ddd9 | 2024-05-21 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | ea9f7216-0358-43a9-96eb-5dad694ae9b8 | 2024-05-15 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Jasmiel | DROSPIRENONE AND ETHINYL ESTRADIOL | Afaxys Pharma, LLC | 1a3211f8-41f5-4905-a466-0d79add5fdad | 2024-05-14 | Boxed warning, Warnings, Adverse reactions | 748797 |
| ALYACEN 1/35 | NORETHINDRONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | a45ee86e-69ca-49a5-8990-5dde52d4a522 | 2024-05-07 | Warnings, Adverse reactions | 748797 749858 312033 |
| Nortrel 28 Day | NORETHINDRONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 33b895e4-b467-41b1-a812-8068cc5bb93e | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 748797 |
| drospirenone and ethinyl estradiol | DROSPIRENONE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 9b1f944b-b05b-4ab0-bcf6-42f426b07c45 | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Cryselle | NORGESTREL AND ETHINYL ESTRADIOL | A-S Medication Solutions | fcf4f8ea-1eb3-4a43-87d2-16f93e904443 | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Naari Pte Limited | b936a6fb-27ed-44de-9199-8c656bcd366e | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Norgestimate and ethinyl estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Naari Pte Limited | 03de435b-b8fb-4faa-a0ec-01e48b5aaae4 | 2024-04-23 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | f1a3bfe0-1057-4120-be7e-d7b3570d5418 | 2024-04-22 | Warnings, Adverse reactions | 748797 |
| desogestrel and ethinyl estradiol | DESOGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | f0323be5-9654-4236-8164-230f51a028cd | 2024-04-22 | Boxed warning, Warnings, Adverse reactions | 748797 |
| Affodel | NORETHINDRONE | Naari Pte. Limited | 8ec64ec8-fbc9-440d-9838-654a605d57da | 2024-04-22 | Warnings, Adverse reactions | T18F433X4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.